Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22,511Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://news.abbvie.com/2025-07-29-AbbVie-Submits-for-U-S-FDA-Approval-of-Combination-Treatment-of-VENCLEXTA-R-venetoclax-and-Acalabrutinib-for-Previously-Untreated-Patients-with-Chronic-Lymphocytic-Leukemia-CLL

PRESS RELEASE
30 Jul 2025

https://www.astrazeneca.com/media-centre/press-releases/2025/fixed-duration-calquence-approved-in-eu-for-1l-cll.html

PRESS RELEASE
07 Jun 2025

https://www.astrazeneca.com/media-centre/press-releases/2025/calquence-combination-approved-in-us-for-1l-mcl.html

PRESS RELEASE
17 Jan 2025

https://www.businesswire.com/news/home/20241003958806/en

BUSINESSWIRE
03 Oct 2024

https://www.astrazeneca.com/media-centre/press-releases/2024/calquence-fixed-duration-combo-improved-1l-cll-pfs.html

PRESS RELEASE
30 Jul 2024

https://www.businesswire.com/news/home/20240616853829/en

BUSINESSWIRE
16 Jun 2024